# Sofinnova Investments' Biotech Investments: 37 Startups in Its Portfolio (2026) > The 37 Biotech startups Sofinnova Investments has backed, by stage: $3.4B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/sofinnova-investments-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 13 - [*CT* City Therapeutics](https://millionrounds.com/company/city-therapeutics) - [Galera Therapeutics](https://millionrounds.com/company/galera-therapeutics) - [*CT* Capstan Therapeutics](https://millionrounds.com/company/capstan-therapeutics) - [SARcode Bioscience](https://millionrounds.com/company/sarcode-bioscience) - [Checkmate Pharmaceuticals](https://millionrounds.com/company/checkmate-pharmaceuticals) - [DNA Script](https://millionrounds.com/company/dna-script) - [*C* Corvidia](https://millionrounds.com/company/corvidia) - [*BT* BioClin Therapeutics](https://millionrounds.com/company/bioclin-therapeutics) - [*ET* Entasis Therapeutics](https://millionrounds.com/company/entasis-therapeutics) - [*CS* CareX SA](https://millionrounds.com/company/carex-sa) - [NextCure](https://millionrounds.com/company/nextcure) - [*B* BioClin](https://millionrounds.com/company/bioclin) - [*VB* Vitra Bioscience](https://millionrounds.com/company/vitra-bioscience) ## Series C and later 13 - [Star Therapeutics](https://millionrounds.com/company/star-therapeutics) - [Coherus Biosciences](https://millionrounds.com/company/coherus-biosciences) - [aTyr Pharma](https://millionrounds.com/company/atyr-pharma) - [Atsena Therapeutics](https://millionrounds.com/company/atsena-therapeutics) - [HotSpot Therapeutics](https://millionrounds.com/company/hotspot-therapeutics) - [Civitas Therapeutics](https://millionrounds.com/company/civitas-therapeutics) - [*R* RefleXion](https://millionrounds.com/company/reflexion) - [Hookipa](https://millionrounds.com/company/hookipa) - [*R* Rgenix](https://millionrounds.com/company/rgenix) - [Antiva Biosciences](https://millionrounds.com/company/antiva-biosciences) - [ENYO Pharma](https://millionrounds.com/company/enyo-pharma) - [*N* Novacea](https://millionrounds.com/company/novacea) - [*A* Antiva](https://millionrounds.com/company/antiva) ## Series A 6 - [*IP* Inozyme Pharma](https://millionrounds.com/company/inozyme-pharma) - [*A* Akuous](https://millionrounds.com/company/akuous) - [*LB* Labrys Biologics](https://millionrounds.com/company/labrys-biologics) - [Dauntless](https://millionrounds.com/company/dauntless) - [*X* XyloCor](https://millionrounds.com/company/xylocor) - [*IB* Intrepida Bio](https://millionrounds.com/company/intrepida-bio) ## Stage not reported 5 - [*C* Cebix](https://millionrounds.com/company/cebix) - [Principia BioPharma](https://millionrounds.com/company/principia-biopharma) - [*Y* YmAbs](https://millionrounds.com/company/ymabs) - [InteKrin](https://millionrounds.com/company/intekrin) - [*K* Karuna](https://millionrounds.com/company/karuna) ## Segment by segment ### Series B 13 startups · $1.1B raised - [*CT* **City Therapeutics**](https://millionrounds.com/company/city-therapeutics) United States $235M - [**Galera Therapeutics**](https://millionrounds.com/company/galera-therapeutics) Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer. United States $219M - [*CT* **Capstan Therapeutics**](https://millionrounds.com/company/capstan-therapeutics) Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases. United States $175M - [**SARcode Bioscience**](https://millionrounds.com/company/sarcode-bioscience) SARcode Bioscience develops an antigen for the treatment of unmet medical needs in ophthalmology, dermatology and inflammatory diseases. United States $98M - [**Checkmate Pharmaceuticals**](https://millionrounds.com/company/checkmate-pharmaceuticals) Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy. United States $69M - [**DNA Script**](https://millionrounds.com/company/dna-script) DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health. France $62M - [*C* **Corvidia**](https://millionrounds.com/company/corvidia) Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases. United States $61M - [*BT* **BioClin Therapeutics**](https://millionrounds.com/company/bioclin-therapeutics) United States $56M ### Series C and later 13 startups · $1.7B raised - [**Star Therapeutics**](https://millionrounds.com/company/star-therapeutics) Star Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, founded in 2018. United States $325M - [**Coherus Biosciences**](https://millionrounds.com/company/coherus-biosciences) Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases. United States $299M - [**aTyr Pharma**](https://millionrounds.com/company/atyr-pharma) aTyr Pharma (Nasdaq: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on United States $181M - [**Atsena Therapeutics**](https://millionrounds.com/company/atsena-therapeutics) Atsena Therapeutics is a clinical-stage gene therapy company based in Durham, North Carolina, focused on developing treatments for United States $150M - [**HotSpot Therapeutics**](https://millionrounds.com/company/hotspot-therapeutics) HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment. United States $145M - [**Civitas Therapeutics**](https://millionrounds.com/company/civitas-therapeutics) Civitas develops pulmonary delivery therapies. United States $122M - [*R* **RefleXion**](https://millionrounds.com/company/reflexion) Reflexion offers holistic fitness through Pilates and Gyrotonic exercise. United States $100M - [**Hookipa**](https://millionrounds.com/company/hookipa) Hookipa GmbH – Private Equity, Finanzierungen, Start-Up Coaching und Vermittlung von Kontakten & Personal. Austria $97M ### Series A 6 startups · $263M raised - [*IP* **Inozyme Pharma**](https://millionrounds.com/company/inozyme-pharma) United States $116M - [*A* **Akuous**](https://millionrounds.com/company/akuous) United States $50M - [*LB* **Labrys Biologics**](https://millionrounds.com/company/labrys-biologics) Labrys Biologics develops treatments for chronic migraine. - $46M - [**Dauntless**](https://millionrounds.com/company/dauntless) Dauntless is a Seattle-area software developer providing point-of-sale and tracking software to the cannabis industry. United States $25M - [*X* **XyloCor**](https://millionrounds.com/company/xylocor) United States $17M - [*IB* **Intrepida Bio**](https://millionrounds.com/company/intrepida-bio) IntrepidaBio is a preclinical biotechnology company focused on developing cancer treatments through innovative drug therapies. United States $9.5M ### Stage not reported 5 startups · $351M raised - [*C* **Cebix**](https://millionrounds.com/company/cebix) Cebix is a biopharmaceutical company focused on the treatment of diabetic complications. United States $96M - [**Principia BioPharma**](https://millionrounds.com/company/principia-biopharma) Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology. United States $90M - [*Y* **YmAbs**](https://millionrounds.com/company/ymabs) United States $80M - [**InteKrin**](https://millionrounds.com/company/intekrin) InteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders. United States $65M - [*K* **Karuna**](https://millionrounds.com/company/karuna) United States $20M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Sofinnova Investments as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with Sofinnova Investments** 37 co-investors](https://millionrounds.com/portfolio-maps/sofinnova-investments-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio)[Sector portfolio **General Catalyst's AI portfolio** 226 startups · $179B](https://millionrounds.com/portfolio-maps/general-catalyst-ai-portfolio)[Sector portfolio **Sequoia Capital's AI portfolio** 209 startups · $543B](https://millionrounds.com/portfolio-maps/sequoia-capital-ai-portfolio) ## Raising from investors like Sofinnova Investments? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)